Genmab Market Sentiment

Genmab AS

GMABNASDAQ

Trade with Public

$55.45

-1.62-2.83%

마지막 업데이트: Nov 2, 2:10 PM

개요 뉴스 실적 전망 이벤트 목표가 재무심리지분 현황 비교 옵션 주식 보고서

실적: Q3 2026 실적이 목 11월 5th에 정규 거래 중 3일 후 후에 발표됩니다.

컨퍼런스 콜: 3일 후 12:00 오후에 컨퍼런스 콜이 예정되어 있습니다.

웹캐스트를 보려면 클릭하세요.

Genmab Market Sentiment - Benzinga

Genmab Market Sentiment

Market sentiment signals for Genmab (GMAB): analyst consensus, short interest, options flow and insider activity.

Key Signals

Analyst Consensus▲ Buy

Short Interest▼ 1.1% short float

Options Flow▲ 0.12 P/C ratio

Insider Activity— N/A

Analyst Consensus

Buy

18 analysts

Options Flow (P/C)

0.12

More calls — Bullish

6,220 calls · 726 puts

Avg Consensus PT

$48

-14.3%

Highest Price Target

$80

+44.3%

Guggenheim

Lowest Price Target

$27

-51.3%

Leerink Partners

Short Interest

1.1%

Rising — Bearish

Insider Activity (30d)

—

Short Interest — % of Float

Recent Analyst Actions

Date	Firm	Analyst & Accuracy	Upside / Downside	PT Change	Action	Rating
Oct 30, 2026	Morgan Stanley	Judah Frommer—	+2.8%	$42 → $57	Maintained	Equal-Weight
Oct 30, 2026	Guggenheim	Michael Schmidt—	+44.3%	$58 → $80	Maintained	Buy
Oct 29, 2026	Truist Securities	Gregory Renza—	+20.8%	$45 → $67	Maintained	Buy
Oct 29, 2026	HC Wainwright & Co.	Raghuram Selvaraju—	+26.3%	$50 → $70	Maintained	Buy
Oct 26, 2026	TD Cowen	Yaron Werber—	-6.2%	$43 → $52	Maintained	Buy
Oct 26, 2026	JP Morgan	James Gordon—	—	—	Upgrade	Neutral→Overweight
Oct 7, 2026	Truist Securities	Asthika Goonewardene—	-18.8%	$40 → $45	Maintained	Buy
Oct 7, 2026	Guggenheim	Michael Schmidt—	+4.6%	$54 → $58	Maintained	Buy
Oct 7, 2026	HC Wainwright & Co.	Raghuram Selvaraju—	-9.8%	$40 → $50	Maintained	Buy
Oct 5, 2026	Guggenheim	Michael Schmidt—	-2.6%	$45 → $54	Maintained	Buy
Sep 14, 2026	HC Wainwright & Co.	Raghuram Selvaraju—	-27.9%	$40 → $40	Maintained	Buy
Aug 7, 2026	Guggenheim	Michael Schmidt—	-24.2%	$40 → $42	Maintained	Buy
Jul 22, 2026	TD Cowen	Yaron Werber—	-22.4%	$32 → $43	Upgrade	Hold→Buy
Jul 2, 2026	HC Wainwright & Co.	Raghuram Selvaraju—	-27.9%	$38 → $40	Maintained	Buy
Jun 23, 2026	HC Wainwright & Co.	Raghuram Selvaraju—	-31.5%	$38 → $38	Maintained	Buy
Apr 30, 2026	HC Wainwright & Co.	Raghuram Selvaraju—	-31.5%	$40 → $38	Maintained	Buy
Mar 27, 2026	Wolfe Research	Kalpit Patel—	-42.3%	$32	Initiate	Outperform
Mar 2, 2026	Wells Fargo	Eva Fortea Verdejo—	-27.9%	$40	Initiate	Overweight
Feb 23, 2026	Guggenheim	Michael Schmidt—	-27.9%	$45 → $40	Maintained	Buy
Feb 18, 2026	HC Wainwright & Co.	Raghuram Selvaraju—	-27.9%	$39 → $40	Maintained	Buy
Feb 17, 2026	Jefferies	Benjamin Jackson—	-25.2%	$42	Reinstates	Buy
Feb 16, 2026	Morgan Stanley	Judah Frommer—	-38.7%	$34	Reinstates	Equal-Weight
Jan 28, 2026	HC Wainwright & Co.	Raghuram Selvaraju—	-29.7%	$39 → $39	Maintained	Buy
Jan 20, 2026	HC Wainwright & Co.	Raghuram Selvaraju—	-29.7%	$41 → $39	Maintained	Buy
Nov 10, 2025	HC Wainwright & Co.	Raghuram Selvaraju—	-26.1%	$40 → $41	Maintained	Buy